Identifying strategies for individualized brain stimulation for Major Depressive Disorder

This webinar has ended. You can watch the recorded session here. 

Welcome to ANT Neuro Educational Webinar Series! 

In this webinar, we are happy to introduce TMS brain stimulation strategies for optimized MDD treatment. 

Standard 10 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) is an effective treatment for Major Depressive Disorder (MDD) with response rates between 30-40%. We show that rTMS-induced changes in functional brain connectivity can predict clinical outcome and that the proximity of the individual alpha frequency to the stimulation frequency is associated with better clinical outcome. We will present a procedure developed for the interrogation of frequencies between 3 – 17 Hz to identify the optimal stimulation frequency for MDD treatment. Individualized brain stimulation is highly promising for increasing clinical response rates. Biomarkers and early response predictors are critical in developing the appropriate stimulation strategy. 

The presenter is Dr. Juliana Corlier who received her Ph.D in Cognitive Neuroscience from the Sorbonne Universities in Paris, France. Dr. Corlier has completed her postdoctoral training at the UCLA Neuromodulation Division under the supervision of Dr. Andrew Leuchter. In her current work as an assistant project scientist, she oversees projects that combine neuronavigated TMS, simultaneous EEG recordings and multimodal neuroimaging, focusing on the development of biomarkers and individualized stimulation approaches to TMS treatment.

This session will be followed by a live demonstration of a navigated TMS setup by ANT Neuro application specialist/ product management team. 

Looking forward to welcoming you to this webinar! 

Organization team
ANT Neuro Education Department
[event ID: 4293] 

Disclaimer: The information provided is for clinical research only, and no medical advice will be given by ANT Neuro.